C. Silvain

发表

Predicting relapse in patients with severe alcohol use disorder: The role of alcohol insight and implicit alcohol associations.

X. Noël, A. Chatard, N. Langbour, 2020, Addictive behaviors.

Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: results from two French tertiary centres.

P. Michel, R. Bensadoun, D. Tougeron, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference.

V. de Lédinghen, D. Samuel, J. Dumortier, 2019, Journal of hepatology.

[Can septicemia and ascitic fluid infections in cirrhotic patients be treated by the oral route alone?].

G. Grollier, C. Silvain, J. Rouffineau, 1989, Gastroenterologie clinique et biologique.

Management of esophageal adenocarcinoma.

J. Richer, D. Tougeron, C. Silvain, 2011, Journal of visceral surgery.

Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection.

P. Sosner, C. Silvain, G. Le Moal, 2012, Atherosclerosis.

Th‐17 response and antimicrobial peptide expression are uniformly expressed in gastric mucosa of Helicobacter pylori‐infected patients independently of their clinical outcomes

X. Dray, D. Tougeron, F. Morel, 2018, Helicobacter.

Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study.

J. Taïeb, D. Vernerey, F. Bonnetain, 2016, Journal of the National Cancer Institute.

Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre study.

J. Taïeb, D. Vernerey, J. Pagès, 2015, European journal of cancer.

Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers

J. Sabourin, R. Guimbaud, M. Auriault, 2022, International journal of molecular sciences.

HÉMORRAGIES DIGESTIVES

C. Silvain, 2004 .

Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study

V. de Lédinghen, D. Samuel, J. Dumortier, 2018, Alimentary pharmacology & therapeutics.

Value of endoscopic ultrasonography in the diagnosis of common bile duct stones: comparison with surgical exploration and ERCP.

S. Chaussade, L. Palazzo, G. Roseau, 1995, Gastrointestinal endoscopy.

Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases

A. Herbelin, J. Gombert, É. Salame, 2019, Front. Immunol..

Traitements antiviraux de l’infection par le virus de l’hépatite C

C. Silvain, 1999 .

Increased serum immunoglobulin G1 levels in hepatitis C virus infection

L. Musset, P. Cacoub, P. Opolon, 1995, Hepatology.

Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study.

T. de Baère, C. Lepage, G. Deplanque, 2020, Clinics and research in hepatology and gastroenterology.

Clinical outcome of portal vein thrombosis in patients with digestive cancers: A large AGEO multicenter study.

S. Doat, J. Bachet, D. Tougeron, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort

A. Pariente, J. Cadranel, C. Rabaud, 2010, European journal of gastroenterology & hepatology.

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.

V. de Lédinghen, P. Marcellin, D. Thabut, 2019, Gastroenterology.

Epidemiological characteristics and medical follow-up of 61 patients with acute hepatitis C identified through the hepatitis C surveillance system in France

P. Pradat, E. Delarocque-Astagneau, C. Brouard, 2007, Epidemiology and Infection.

Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study.

D. Thabut, D. Samuel, A. Duhamel, 2022, The lancet. Gastroenterology & hepatology.

Effects of Octreotide on Lower Esophageal Sphincter in Patients with Cirrhosis and Portal Hypertension

T. Barrioz, P. Ingrand, C. Silvain, 1998, Digestive Diseases and Sciences.

Cirrhosis and bleeding: the need for very early management.

S. Ragot, C. Pilette, C. Silvain, 2003, Journal of hepatology.

Early administration of vapreotide for variceal bleeding in patients with cirrhosis.

D. Valla, F. Durand, F. Saliba, 2001, The New England journal of medicine.

Anti-inflammatory drugs and variceal bleeding: a case-control study

V. de Lédinghen, D. Heresbach, P. Ingrand, 1999, Gut.

Predictive factors of variceal bleeding control by emergency sclerotherapy. Multicenter Group.

P. Ingrand, C. Silvain, M. Beauchant, 1998, Gastroenterologie clinique et biologique.

Non-steroidal anti-inflammatory drugs and variceal bleeding: a case-control study.

V. de Lédinghen, T. Barrioz, P. Ingrand, 1996, Journal of hepatology.

Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial

D. Sautereau, D. Dhumeaux, P. Ingrand, 1993, Hepatology.

A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage

D. Sautereau, P. Ingrand, C. Silvain, 1990, Hepatology.

Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.

V. de Lédinghen, T. Asselah, D. Thabut, 2020, Journal of hepatology.

Evaluation of monoclonal antibodies with specificity for human IgA, IgA subclasses and allotypes and secretory component. Results of an IUIS/WHO collaborative study.

G. Carlone, R. Jefferis, M. Goodall, 1996, Journal of immunological methods.

A Placebo‐Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

V. de Lédinghen, P. Potier, F. Zoulim, 2018, The New England journal of medicine.

Prevention of viral hepatitis C: assessment of a comic strip-based information campaign targeting adolescents.

I. Ingrand, C. Silvain, M. Beauchant, 2004, European journal of public health.

Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis

M. Samson, J. Lecron, C. Piquet-Pellorce, 2017, Oncotarget.

Cardiovascular events in chronic hepatitis C: prognostic value of liver stiffness evolution

D. Tougeron, E. Gand, C. Silvain, 2015, European journal of gastroenterology & hepatology.

Session 6 ‒ Treatment of the Acute Bleeding Episode

A. Burroughs, J. Bosch, C. Silvain, 2008 .

Subcutaneous octreotide for the prevention of early variceal rebleeding

C. Silvain, M. Ripault, S. Bouquet, 1996, Hepatology.

Cocaine-induced acute hepatitis: A diagnosis not to forget.

B. Fauconneau, M. Pérault-Pochat, S. Pain, 2020, Clinics and research in hepatology and gastroenterology.

French hepatitis C care cascade: substantial impact of direct-acting antivirals, but the road to elimination is still long

V. de Lédinghen, A. Rachas, E. Delarocque-Astagneau, 2020, BMC Infectious Diseases.

Trends of hepatitis C screening in France through Rena-VHC and hepatology reference centres surveillance systems, 2000-2007.

J. Desenclos, D. Dhumeaux, E. Delarocque-Astagneau, 2009 .

ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts

V. de Lédinghen, P. Marcellin, S. Chevret, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications

V. de Lédinghen, A. de Gottardi, D. Valla, 2022, American journal of hematology.

High-Fat Diet-Induced IL-17A Exacerbates Psoriasiform Dermatitis in a Mouse Model of Steatohepatitis.

H. Yssel, L. Favot, M. Samson, 2016, The American journal of pathology.

[Severe pulmonary embolism after obturation of gastric varices with a butyl-cyanoacrylate and lipiodol combination].

J. Richer, C. Silvain, M. Beauchant, 1999, Gastroenterologie clinique et biologique.

Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin

P. Marquet, A. Tran, C. Trépo, 2016, Therapeutic drug monitoring.

E. Andrès, L. Chiche, J. Berthelot, 2012, Medicine.

Long-term outcome of severe radiation enteritis treated by total parenteral nutrition

P. Ingrand, C. Matuchansky, M. Carretier, 1992, Digestive Diseases and Sciences.

Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment.

V. de Lédinghen, P. Couzigou, P. Marcellin, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Randomised trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin

T. Barrioz, P. Ingrand, V. Ledinghen, 1994, The Lancet.

Gender differences in vascular reactivity of aortas from rats with and without portal hypertension

G. Mauco, M. Carretier, C. Silvain, 2005, Journal of gastroenterology and hepatology.

SARAH: a randomised controlled trial comparing efficacy and safety of selective internal radiation therapy (with yttrium-90 microspheres) and sorafenib in patients with locally advanced hepatocellular carcinoma

G. Chatellier, M. Ronot, V. Vilgrain, 2017 .

Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid:

I. Durand-zaleski, R. Moreau, D. Valla, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Treatment and long-term outcome of chronic radiation esophagitis after radiation therapy for head and neck tumors

T. Barrioz, P. Babin, C. Matuchansky, 1993, Digestive Diseases and Sciences.

Pharmacological inhibitors of the mevalonate pathway activate pro-IL-1 processing and IL-1 release by human monocytes.

L. Cuisset, B. Massonnet, L. Favot, 2009, European cytokine network.

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.

M. Ziol, V. de Lédinghen, P. Marcellin, 2017, Gastroenterology.

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients

M. Ziol, V. de Lédinghen, P. Marcellin, 2018, American heart journal.

Ex vivo cytokine production in psoriatic disease: Towards specific signatures in cutaneous psoriasis and peripheral psoriatic arthritis

F. Morel, J. Lecron, C. Silvain, 2022, Frontiers in Immunology.

Transient Elastography Accurately Screens for Compensated Advanced Chronic Liver Disease in Patients with Ongoing or Recent Alcohol Withdrawal.

R. Moirand, D. Guyader, C. Le Lan, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Chronic Alcohol Consumption Exacerbates the Severity of Psoriasiform Dermatitis in Mice.

F. Morel, J. Lecron, C. Silvain, 2020, Alcoholism, clinical and experimental research.

Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis

V. de Lédinghen, D. Thabut, R. Moreau, 2007, Hepatology.

Prognosis and long-term recurrence of spontaneous bacterial peritonitis in cirrhosis.

P. Ingrand, C. Silvain, M. Beauchant, 1993, Journal of hepatology.

Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case–control study

X. Causse, J. Dumortier, L. Spahr, 2018, European journal of gastroenterology & hepatology.

Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis

C. Silvain, J. Breux, B. Becq-giraudon, 2004, European Journal of Clinical Pharmacology.

[Peripheral neuropathies and chronic hepatitis C: a frequent association?].

J. Vallat, J. Goujon, C. Silvain, 1998, Gastroentérologie Clinique et Biologique.

Structurally abnormal immunoglobulins in human immunoproliferative disorders

A. Khamlichi, M. Cogné, J. Preud’homme, 1992 .

Hepatitis C virus and organ transplantation

G. Agius, C. Silvain, M. Beauchant, 1992, Hepatology.

Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation.

J. Dumortier, F. Durand, N. Kamar, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Treatment of chronic hepatitis C in patients unresponsive to interferon. Interest of re-treatment combining interferon induction therapy and ribavirin (a multicenter pilot study).

B. Giraudeau, X. Causse, Y. Bacq, 2005, Gastroenterologie clinique et biologique.

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)

P. Marcellin, F. Roudot-thoraval, F. Zoulim, 2016, Hepatology.

Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients.

C. Chagneau, C. Silvain, M. Ripault, 1999, Journal of hepatology.

Preventing biliary stent occlusion

T. Barrioz, R. Sutton, I. Finnie, 1994, The Lancet.

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

Rachida Lebtahi, Mohamed Bouattour, Christophe Aubé, 2017, The Lancet. Oncology.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Journal of hepatology.

Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult‐to‐treat primary biliary cholangitis

T. Berg, F. Carrat, P. Potier, 2021, Alimentary pharmacology & therapeutics.

Isotypic and allotypic analysis with monoclonal antibodies and jacalin of 309 serum monoclonal IgA from French and Japanese myeloma patients.

Y. Ko, P. Aucouturier, L. Musset, 1992, Immunology letters.

High plasma levels of the pro-inflammatory cytokine IL-22 and the anti-inflammatory cytokines IL-10 and IL-1ra in acute pancreatitis.

J. Tasu, D. Tougeron, J. Lecron, 2014, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Papaverine-induced chronic liver disease.

E. Poncin, C. Silvain, G. Touchard, 1986, Gastroenterology.

Quadruplex Real-Time PCR Assay Using Allele-Specific Scorpion Primers for Detection of Mutations Conferring Clarithromycin Resistance to Helicobacter pylori

M. Garnier, C. Silvain, C. Burucoa, 2008, Journal of Clinical Microbiology.

Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen.

X. Causse, Y. Bacq, F. Lunel, 2003, Journal of hepatology.

Emergency endoscopy strategies for improved outcomes.

R. de Franchis, R. Bañares, C. Silvain, 1998, Scandinavian journal of gastroenterology. Supplement.

G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort

J. Dumortier, R. Anty, C. Duvoux, 2015 .

Early Feeding or Enteral Nutrition in Patients with Cirrhosis After Bleeding from Esophageal Varices? (A Randomized Controlled Study)

V. Ledinghen, P. Beau, C. Silvain, 1997, Digestive Diseases and Sciences.

HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation.

D. Samuel, J. Dumortier, C. Cagnot, 2022, Clinics and research in hepatology and gastroenterology.

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study

P. Couzigou, P. Marcellin, J. Pawlotsky, 2005, Journal of viral hepatitis.

Diagnosis of choledocholithiasis: EUS or magnetic resonance cholangiography? A prospective controlled study.

R. Lecesne, V. de Lédinghen, P. Couzigou, 1999, Gastrointestinal endoscopy.

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer.

J. Pagès, C. Collin, D. Tougeron, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Granulomatous hepatitis due to combination of amoxicillin and clavulanic acid

P. Levillain, C. Silvain, M. Beauchant, 2005, Digestive Diseases and Sciences.

Characterization of melatonin binding sites in chicken and human intestines.

M. Bernard, J. Collin, P. Voisin, 1993, European journal of pharmacology.

Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis

C. Silvain, J. Breux, B. Becq-giraudon, 2004, European Journal of Clinical Pharmacology.

Anatomic and radiologic bases of combined transplantation of liver and small intestine in the pig

P. Kamina, J. Richer, M. Carretier, 2005, Surgical and Radiologic Anatomy.

Analysis of factors influencing molecular testing at diagnostic of colorectal cancer

G. Defossez, P. Ingrand, D. Tougeron, 2017, BMC Cancer.

12 Weeks of a Ribavirin‐Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation

J. Dumortier, C. Cagnot, A. Tran, 2018, Hepatology.

Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer

U. Cortes, D. Tougeron, P. Levillain, 2013, Cancer Chemotherapy and Pharmacology.

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.

V. de Lédinghen, S. Imbeaud, J. Zucman‐Rossi, 2018, Gastroenterology.

Efficacy, tolerability and impact on quality of life of selective internal radiation therapy (with yttrium-90 resin microspheres) or sorafenib in patients with locally advanced hepatocellular carcinoma: The SARAH trial.

A. Luciani, R. Perdrisot, G. Chatellier, 2017 .

LBA-001Efficacy, tolerability and impact on quality of life of selective internal radiation therapy (with yttrium-90 resin microspheres) or sorafenib in patients with locally advanced hepatocellular carcinoma: The SARAH trial.

A. Luciani, R. Perdrisot, G. Chatellier, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Primary structure of a monoclonal κ chain in myeloma with light chain deposition disease

A. Khamlichi, M. Cogné, M. Bauwens, 1992 .

Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.

A. Khamlichi, M. Cogné, F. Nau, 1992, Clinical and experimental immunology.

Structurally abnormal immunoglobulins in human immunoproliferative disorders.

A. Khamlichi, M. Cogné, J. Preud’homme, 1992, Blood.

Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma

P. Ingrand, J. Tasu, S. Velasco, 2016, European Radiology.

[How to prevent and to treat bleeding from gastric or ectopic or from portal hypertension gastropathy].

C. Silvain, 2004, Gastroenterologie clinique et biologique.

[Acute pseudo-angio-cholitic cholestasis during melphalan therapy].

T. Barrioz, C. Silvain, G. Touchard, 1993, Gastroentérologie Clinique et Biologique.

Direct‐acting antiviral agent–based regimen for HCV recurrence after combined liver‐kidney transplantation: Results from the ANRS CO23 CUPILT study

V. de Lédinghen, D. Samuel, J. Dumortier, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A human myeloma IgA with a hybrid heavy chain resulting from putative somatic gene conversion

M. Cogné, J. '. Homme, P. Aucouturier, 1993, European journal of immunology.

[Acute intermittent porphyria associated with hyperaldosteronism and inappropriate antidiuretic hormone secretion syndrome].

O. Pourrat, C. Silvain, M. Ripault, 1998, Gastroenterologie clinique et biologique.

Evaluation of Longitudinal Exposure to Tacrolimus as a Risk Factor of Chronic Kidney Disease Occurrence Within the First-year Post-Liver Transplantation

X. Causse, A. Prémaud, P. Marquet, 2020, Transplantation.

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.

Albert Tran, Vincent Leroy, Dominique Larrey, 2018, Gastroenterology.

Early liver transplantation for corticosteroid non-responders in acute severe autoimmune hepatitis: the SURFASA score.

V. de Lédinghen, P. Potier, D. Samuel, 2021, Journal of hepatology.

Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis.

M. Ziol, V. de Lédinghen, J. Zucman‐Rossi, 2022, Journal of hepatology.

Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial.

J. Vinel, C. Duvoux, G. Thiéfin, 2009, Annals of internal medicine.

Recipient Selection for Optimal Utilization of Discarded Grafts in Liver Transplantation

X. Causse, P. Bucur, A. Tellier, 2018, Transplantation.

Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis

R. Cavallazzi, M. Mcphail, A. Burroughs, 2017, Annals of Intensive Care.

Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. Potential role for IFN-gamma.

R. Monteiro, A. Lehuen, P. Launay, 1995, Journal of immunology.

Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.

D. Thabut, A. Duhamel, J. Salleron, 2013, JAMA.

Why do liver transplant patients so often become obese? The addiction transfer hypothesis.

D. Belin, A. Benyamina, N. Jaafari, 2015, Medical hypotheses.

Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)

V. de Lédinghen, P. Marcellin, F. Roudot-thoraval, 2015, Gut.

A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)

P. Potier, F. Zoulim, A. Rousseau, 2017 .

Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.

V. Vilgrain, I. Colle, D. Valla, 2020, Clinics and research in hepatology and gastroenterology.

Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll‐like receptor 9 activation

B. Massonnet, J. Lecron, C. Silvain, 2009, Clinical and experimental immunology.

Prospective study on the application of the Baveno II Consensus Conference criteria in patients with cirrhosis and gastrointestinal bleeding.

J. Vinel, P. Calès, D. Lebrec, 2000, Journal of hepatology.

Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication

V. de Lédinghen, P. Marcellin, E. Letouzé, 2018, Hepatology.

Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX)

S. Ragot, J. Godet, J. Tasu, 2020, Oncoimmunology.

Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme

V. de Lédinghen, F. Zoulim, D. Guyader, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region

G. Defossez, P. Ingrand, I. Ingrand, 2008, European journal of gastroenterology & hepatology.

Diagnostic Accuracy of a Noninvasive Test for Detection of Helicobacter pylori and Resistance to Clarithromycin in Stool by the Amplidiag H. pylori+ClariR Real-Time PCR Assay

T. Barrioz, M. Pichon, É. Vuillemin, 2020, Journal of Clinical Microbiology.

[How many cirrhotic patients may receive propranolol after digestive hemorrhage?].

M. Carretier, C. Silvain, M. Beauchant, 1985, Gastroentérologie Clinique et Biologique.

Pseudocystic hepatic metastasis: Unusual onset of carcinoid tumor

C. Silvain, M. Morichau-Beauchant, I. Besson, 1991, Digestive Diseases and Sciences.

[Nodular regenerative hyperplasia of the liver and Turner syndrome].

V. de Lédinghen, L. Palazzo, M. Fabre, 1994, Gastroentérologie Clinique et Biologique.

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)

V. de Lédinghen, P. Marcellin, S. Chevret, 2015, Hepatology.

Early liver transplantation for severe alcoholic hepatitis not responding to medical treatment: results of the French-Belgian prospective study QuickTrans

D. Thabut, D. Samuel, A. Duhamel, 2020 .

Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatients.

R. Moreau, P. Nahon, A. Tran, 2013, World journal of hepatology.

Hepatic fibrin-ring granulomas in giant cell arteritis.

P. Levillain, C. Silvain, P. Roblot, 1993, Gastroenterology.

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance

V. de Lédinghen, T. Asselah, D. Thabut, 2021, JHEP Reports.

LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program

F. Carrat, F. Zoulim, D. Guyader, 2015 .

Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt

J. Dumortier, F. Durand, A. Tran, 2016 .

Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation.

L. Cuisset, B. Massonnet, L. Favot, 2009, European cytokine network.

The impact of the prevention programme of hepatitis C over more than a decade: the French experience

J. Desenclos, F. Roudot-thoraval, D. Dhumeaux, 2009, Journal of viral hepatitis.

Evaluation of hepatic iron concentration heterogeneities using the MRI R2* mapping method.

P. Ingrand, G. Herpe, J. Tasu, 2018, European journal of radiology.

Non‐virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort

P. Marcellin, E. Letouzé, D. Thabut, 2019, Journal of viral hepatitis.

Rapid and large-scale implementation of HCV treatment advances in France, 2007–2015

V. de Lédinghen, E. Delarocque-Astagneau, C. Brouard, 2017, BMC Infectious Diseases.

Treatment and prognosis of acute severe autoimmune hepatitis

M. Rudler, P. Potier, D. Samuel, 2017 .

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation - The CO23 ANRS CUPILT study.

Leroy, D. Samuel, J. Dumortier, 2016 .

Validation of a screening algorithm for hepatic fibrosis by Doppler ultrasound and elastography in a general population

V. Vilgrain, J. Correas, T. Decaens, 2023, Acta radiologica.

Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program

F. Carrat, F. Zoulim, D. Guyader, 2015 .

[Epidemiology and management of care of hepatitis C infection in the Poitou-Charentes region in 1997 and 2000].

G. Defossez, I. Ingrand, C. Silvain, 2003, Gastroenterologie clinique et biologique.

[Hepatobiliary complications of total parenteral nutrition].

C. Matuchansky, M. Carretier, P. Beau, 1992, Chirurgie; memoires de l'Academie de chirurgie.

Short-term and long-term vital outcomes of cirrhotic patients admitted to an intensive care unit

S. Ragot, C. Silvain, M. Beauchant, 2010, European journal of gastroenterology & hepatology.

Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications

V. de Lédinghen, A. de Gottardi, D. Valla, 2022 .

Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease.

S. Saidman, A. Zeevi, R. Duquesnoy, 1995, Hepato-gastroenterology.

Sclerotherapy with or without octreotide for acute variceal bleeding.

D. Heresbach, P. Ingrand, M. Becker, 1995, The New England journal of medicine.

Somatostatin and acute variceal hemorrhage.

C. Silvain, M. Beauchant, E. Fort, 1991, Gastroenterology.

Acute variceal bleeding: Still searching for the right treatment

T. Schubert, P. Ingrand, J. Valenzuela, 1990, Hepatology.

Liver fibrosis is associated with cutaneous inflammation in the imiquimod‐induced murine model of psoriasiform dermatitis

L. Favot, F. Morel, N. Venisse, 2018, The British journal of dermatology.

PrednisoloneWith vsWithout Pentoxifylline and Survival of PatientsWith Severe Alcoholic Hepatitis

D. Thabut, A. Duhamel, J. Salleron, 2013 .

Increased immunoglobulin A in alcoholic liver cirrhosis: exploring the response of B cells to Toll‐like receptor 9 activation

B. Massonnet, J. Lecron, C. Silvain, 2009, Clinical and experimental immunology.

Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort

P. Nahon, N. Ganne-Carrié, R. Anty, 2023, European journal of gastroenterology & hepatology.